Randomized, double‐blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy

Hepatic encephalopathy-Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998

2002 • 1,925 citations

Rifaximin Treatment in Hepatic Encephalopathy

2010 • 1,150 citations

The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus

2013 • 366 citations

Review article: the design of clinical trials in hepatic encephalopathy - an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement

2011 • 318 citations

A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.

1994 • 154 citations

Phase I study of phenylacetate administered twice daily to patients with cancer

1995 • 127 citations

Hepatic Encephalopathy

2008 • 104 citations

Development of a clinical hepatic encephalopathy staging scale

2007 • 96 citations

Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate

2012 • 88 citations

Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: Safety, pharmacokinetics and ammonia control

2010 • 83 citations

Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake

2012 • 70 citations

Ammonia control in children with urea cycle disorders (UCDs); Phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate

2011 • 68 citations

Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis

2010 • 66 citations

An Algorithm for the Management of Hepatic Encephalopathy

2007 • 53 citations

Ammonia Control in Children Ages 2 Months through 5 Years with Urea Cycle Disorders: Comparison of Sodium Phenylbutyrate and Glycerol Phenylbutyrate

2013 • 43 citations

Glycerol Phenylbutyrate in Patients With Cirrhosis and Episodic Hepatic Encephalopathy: A Pilot Study of Safety and Effect on Venous Ammonia Concentration

2013 • 25 citations

195 RIFAXIMIN DECREASES VENOUS AMMONIA CONCENTRATIONS AND TIME-WEIGHTED AVERAGE AMMONIA CONCENTRATIONS CORRELATE WITH OVERT HEPATIC ENCEPHALOPATHY (HE) AS ASSESSED BY CONN SCORE IN A 6-MONTH STUDY

2010 • 10 citations

Abstract 2932: Role of death receptor 5 (DR5) in apoptosis induced by anticancer agents in colon cancer cells

2015 • 1 citations